BHC | tickerfilter.com

Fundamental analysis

56%

Profitability 55%

Dept financing 43%

Liquidity 63%

Performance 59%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

-9.58%

1 Month

-10.03%

3 Months

-21.11%

6 Months

-26.60%

1 Year

-24.76%

2 Year

-30.13%

Key data

Stock price

$5.38

P/E Ratio

16.40

DAY RANGE

$5.36 - $5.51

EPS

$0.42

52 WEEK RANGE

$4.25 - $8.68

52 WEEK CHANGE

-$23.14

MARKET CAP

2.575 B

YIELD

N/A

SHARES OUTSTANDING

370.562 M

DIVIDEND

N/A

EX-DIVIDEND DATE

N/A

NEXT EARNINGS DATE

07-30-2025

BETA

0.00

PUBLIC FLOAT

N/A

AVERAGE 10 VOLUME

$3,223,669

AVERAGE 30 VOLUME

$2,627,372

Company detail

CEO: Thomas J. Appio
Region: US
Website: bauschhealth.com
Employees: 19,900
IPO year: 2006

Issue type:
Market: NYSE
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

Bausch Health Companies Inc. develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products. The Salix segment provides gastroenterology products in the United States. The Ortho Dermatologics segment provides dermatological products in United States; and Solta medical aesthetic devices internationally.

BHC - Bausch Health Companies Inc